Coupang's EBITDA Trajectory Triggers Price Target Boost By This Analyst

Mizuho analyst James Lee maintained Coupang Inc CPNG with a Neutral and raised the price target from $18 to $22.
Coupang clocked 12.5% revenue growth in the second quarter to $5.04 billion, missing the consensus of $5.06 billion.
EPS was $(0.04), beating the consensus of $(0.11).
He highlighted that CPNG reported better than expected EBITDA due to its efforts to increase efficiency in core products while moderating investments in developing offerings.
As a result, FY22 EBITDA guidance increased meaningfully from less than -$400 million to positive for the entire year.
He raised the FY25 EBITDA estimate by 10% to $2.5 billion with a better than anticipated margin outlook.
While he was encouraged by the EBITDA trajectory through cost management, his Neutral rating reflected CPNG’s premium valuation compared to global peers and ongoing competitive concerns.
Price Action: CPNG shares traded lower by 4.66% at $18.84 on the last check Thursday.

Analyst Calendar